Akihito Tsubota - Concepedia

Author

Akihito Tsubota

Also Known As

A TSUBOTA, A Tsubota, A. TSUBOTA, A. Tsubota, AKIHITO TSUBOTA, Akihito TSUBOTA, Akihito Tsubota, Hiroshi Abe, Ji-Dong Jia, K. Ikeda

332

Publications

9.2K

Citations

H-Index

109

Concepts

All Affiliations

Toranomon Hospital Jikei University School of Medicine Chiba Hokusou Hospital Nippon Medical School Shinmatsudo Central General Hospital

About

Akihito Tsubota is an author at Toranomon Hospital specializing in medicine, viral hepatitis, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	69	3.4K
2	Health Sciences	6	6	661
3	Public Health	5	5	245
4	Engineering	2	2	305
5	Natural Sciences	2	2	73

Akihito Tsubota

166

Publications

8.6K

Citations

H-Index

Page 1

	Year	Citations
A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis Akihito Tsubota, Kazuaki Chayama, Masahiro Kawanishi Hepatology	1993	535
Effect of Interferon Therapy on Hepatocellular Carcinogenesis in Patients With Chronic Hepatitis Type C: A Long–Term Observation Study of 1,643 Patients Using Statistical Bias Correction With Proportional Hazard Analysis Kenji Ikeda, Satoshi Saitoh, Yasuji Arase, Hepatology ImmunologyPathologyStatistical Bias CorrectionChronic Hepatitis CCirrhosis	1999	465
Factors predictive of response to interferon-α therapy in hepatitis C virus infection Akihito Tsubota Hepatology	1994	444
Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients Kenji Ikeda, Satoshi Saitoh, Yoshiyuki Suzuki, Journal of Hepatology Hepatitis DHepatologyDisease ProgressionViral HepatitisImmunology	1998	435
The long term efficacy of glycyrrhizin in chronic hepatitis C patients Yasuji Arase, Kenji Ikeda, Naoya Murashima, Cancer	1997	404
Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy Kazuaki Chayama, Yoshiyuki Suzuki, Masahiro Kobayashi, Hepatology Viral ReplicationImmunologyHepatitis BPathologyAmino Acid Substitution	1998	375
Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor—A prospective randomized study of hepatitis C virus-related liver cancer Kenji Ikeda, Yasuji Arase, Satoshi Saitoh, Hepatology	2000	357
Factors predictive of response to interferon-α therapy in hepatitis C virus infection Akihito Tsubota, Kazuaki Chayama, Kenji Ikeda, Hepatology	1994	324
Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma Kenji Ikeda, Satoshi Saitoh, Akihito Tsubota, Cancer	1993	253
A novel magnetic crystal–lipid nanostructure for magnetically guided in vivo gene delivery Yoshihisa Namiki, Tamami Namiki, Hiroshi Yoshida, Nature Nanotechnology NanoparticlesNanomedicineEngineeringTherapeutic NanomaterialsVivo Gene Delivery	2009	242

Page 1